B
IRadimed Corporation IRMD
$70.32 $0.751.08% NASDAQ
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
52-Week Range
P/E (TTM)
EPS (TTM)

06/30/2025 03/31/2025 12/31/2024 09/30/2024 06/30/2024
Net Income 10.80% 10.39% 11.87% 14.09% 26.95%
Total Depreciation and Amortization -3.22% -2.86% 6.85% 722.71% 628.69%
Total Amortization of Deferred Charges -- -- -- -- --
Total Other Non-Cash Items 76.31% -15.41% 28.69% 12.92% 10.84%
Change in Net Operating Assets 151.04% 145.59% 163.43% 141.39% -350.04%
Cash from Operations 71.49% 104.95% 90.30% 87.03% 4.56%
Capital Expenditure -476.12% -769.22% -7.59% 19.81% 68.16%
Sale of Property, Plant, and Equipment -- -- -- -- --
Cash Acquisitions -- -- -- -- --
Divestitures -- -- -- -- --
Other Investing Activities -52.20% -34.17% -43.28% 4.87% 36.86%
Cash from Investing -389.62% -535.35% -10.11% 18.52% 64.58%
Total Debt Issued -- -- -- -- --
Total Debt Repaid -- -- -- -- --
Issuance of Common Stock -84.77% -83.25% -83.25% 2,265.75% 110.35%
Repurchase of Common Stock -30.68% -18.59% -12.73% -53.25% -60.70%
Issuance of Preferred Stock -- -- -- -- --
Repurchase of Preferred Stock -- -- -- -- --
Total Dividends Paid 17.73% 1.42% -3.44% 10.94% 25.31%
Other Financing Activities -- -- -- -- --
Cash from Financing 13.82% -1.78% -4.97% 10.38% 23.80%
Foreign Exchange rate Adjustments -- -- -- -- --
Miscellaneous Cash Flow Adjustments -- -- -- -- --
Net Change in Cash 64.46% 121.50% 130.15% 156.25% 142.82%